Lv1
30 积分 2024-12-11 加入
118TiP A multicenter, randomized, double-blind, placebo-controlled phase III trial of camrelizumab plus chemotherapy with or without radiation therapy (RT) as first-line treatment for patients with brain metastatic non-small cell lung cancer (BM-NSCLC; CTONG2003): Trial in progress
2小时前
已完结
Biological Properties of 3D-Printed Zirconia Implants with p-Cell Structures
1个月前
已完结
皖公网安备34019202002308
